- Active not recruitingPHASE2
A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease
This study looks at a new drug, axatilimab, combined with an existing one, ruxolitinib, to treat a condition called chronic graft-versus-host disease (cGVHD). It aims to see how safe and effective this new combination is.
For: Chronic Graft-versus-host-diseaseUnited States · Belgium · Canada - RecruitingPHASE2
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
This study is testing a new medicine called axatilimab for chronic graft-versus-host disease (cGVHD) in people who haven't responded well to other treatments. It will see how well axatilimab works at three different dose levels and if it’s safe to use.
For: Chronic Graft-versus-host-diseaseUnited States · Australia · Belgium - Active not recruitingPHASE2
MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
This study is looking at a new medicine called axatilimab for people with Idiopathic Pulmonary Fibrosis (IPF). We want to see if it's safe and effective in slowing down this lung condition. It's a Phase 2 trial, meaning it's still in earlier stages of testing.
For: Idiopathic Pulmonary FibrosisAustralia · Belgium · Canada